Since Mutp53 has been shown to affect cancer migration, invasion, and cancer stemness in addition to cell proliferation (28), to understand whether FAO is involved in Mutp53-promoted tumor properties, we suppressed cellular FAO activity with etomoxir (ETO), the pan-CPT1 inhibitor. Here, RUNX1T1 is linked to cancer.